GlassScriptPhysician profile
Dinesh Arora
NPI 1104323641
$7,710.38
in general payments reported to CMS, 2019-2025
8 companies · $6,527 in 2025
The $6,527 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $224 · 2024: $959 · 2025: $6,527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,312 · Education: $2,750 · Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,312.04 |
| Education | $2,750.00 |
| Food and Beverage | $648.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,578.80 | 2024-2025 | |
| Tela Bio, INC. | $762.29 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $148.27 | 2023 | |
| Integra Lifesciences Corporation | $75.56 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $73.58 | 2025 | Phasix Mesh |
| Ethicon US, LLC | $35.11 | 2025 | Harmonic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.84 | 2025 | Lifevest |
| Coastal Medical Technologies LLC | $15.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dinesh Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.